Fraud Detection and Prevention Market to Reach USD 153.91 Billion by 2030, Driven by Real-Time Analytics and AI IntegrationJuly 6, 2025
Lilly’s weight-loss treatment Zepbound becomes the first FDA-approved drug for sleep apnea.December 24, 20240 By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly’s (NYSE:) weight-loss treatment Zepbound for…